eu efre logo

New Publication by A. Dityatev


The CBBS congratulates Alexander Dityatevs group, located at the German Center for Neurodegenerative Diseases (DZNE), on their latest publication in the Journal of Clinical Investigation.

The important study shows that a one-week treatment with a new inhibitor of matrix metalloproteinases can suppress epileptogenesis in a mouse model of the status epilepticus. Accure Therapeutics is bringing this drug into clinical trials - expected in 2022 - as a result of a collaboration between several academic groups and a biotech company funded by EU ITN ECMED.

Read more here.

Save the Date: CBBS 15 jähriges Jubiläum

25.10.2022, ab 18:00 Uhr, Kaiser-Otto-Saal im Kulturhistorischen Museum

Save the Date: CBBS Mitgliederversammlung

26.10.2022, ab 9:00 Uhr, Ebbinghaus Lecture Hall, LIN

Best Paper Of The Year 2021

Das CBBS sucht das beste Paper aus dem Jahr 2021. Jetzt Bewerben!

weitere Meldungen



Otto-von-Guericke-Universität Magdeburg

LIN Leibnizinstitut für Neurobiologie Magdeburg


CBBS Graduierten Logo